New stable version has been published. It contains brand new as well as significant upgrades of the existing features. All of them are listed below and in the manual.

- hERG genetic variability simulation and analysis (built-in and user-defined mutations/polymorphisms)

- built-in functional description of the most commonly found polymorphic variant (K897T)

- NEurCaucasian population description regarding the polymorphic variants

New stable version has been published. It contains brand new as well as significant upgrades of the existing features. All of them are listed below and in the manual.

- new element in menu and new usability - panel 'drug physiology' allows to include the drugs triggered positive and negative modification of the physiological parameters namely plasma ionic concentrations (K⁺, Na⁺, Ca²⁺) and heart rate (stimulation period); drugs causing such effects are i.e. beta-2-adrenomimetics which do not significantly modify ionic currents (low plasma concentration) but their usage can be connected with the increase risk of heart arrhythmia (heart rate elevation by adrenergic stimulation and plasma potassium level decrease)

- panel 'cardiomyocytes' contains new features which allow to define the population variability of left ventricular heart wall thickness; it can be done either in non-physiological (CV) or physiological mode; the latter one comes from the Sjögren model defining sex-age-LVW thickness correlation

- population variability in the heart rate can be now incorporated in the 'settings' panel where the default CV value (equal to 0) can be changed to any other number; it is a first step announcing totally new feature which will be incorporated in version 2.0 - model describing sex related circadian rhythm of the heart rate

- results file comes with the detailed analysis of the psedudoECG outputted by the system; it contains QT/QTc (Fridericia correction - Ref 1 and Ref 2) interval analysis individually for all patients included into the virtual clinical trial